Internal Medicine, Rheumatology · Denver, CO
NPI
1316168834
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
100 Cook St Ste 408
Denver, CO, 80206
Phone (720) 516-9424
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,547
107 services
Medicare patients, 2024
11
Average age 68
Drug cost, 2024
$2.2M
3,216 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Rebecca E Gordon prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 557 prescriptions and refills. In total Rebecca E Gordon wrote 3,216 Medicare prescriptions that cost $2.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-05.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Methotrexate Methotrexate Sodium | 557 | 1,473 | 151 | $12K |
| Hydroxychloroquine Sulfate Generic | 477 | 1,326 | 139 | $16K |
| Prednisone Generic | 457 | 789 | 136 | $4,478 |
| Enbrel Sureclick Etanercept | 174 | 177 | 17 | $811K |
| Leflunomide Generic | 127 | 336 | 33 | $3,517 |
| Meloxicam Generic | 90 | 190 | 35 | $698 |
| Celecoxib Generic | 90 | 175 | 28 | $1,561 |
| Sulfasalazine Generic | 87 | 185 | 20 | $4,264 |
| Amjevita(Cf) Autoinjector Adalimumab-Atto | 77 | 79 | 13 | $74K |
| Xeljanz Tofacitinib Citrate | 68 | 76 | Under 11 | $190K |
| Mycophenolate Mofetil Generic | 67 | 176 | 22 | $12K |
| Leucovorin Calcium Generic | 64 | 164 | 19 | $945 |
| Allopurinol Generic | 64 | 188 | 15 | $727 |
| Sulfasalazine Dr Sulfasalazine | 52 | 117 | 18 | $3,267 |
| Rasuvo Methotrexate/Pf | 48 | 48 | Under 11 | $19K |
Brand drugs: - claims; generic drugs: 2,326 claims; opioid claims: 26.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Rebecca E Gordon were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.